OrthoSensor, a company focused on smart orthopedic devices, received $19 million while Pure Life Renal of Hollywood, a dialysis company, raised $10.5 million.
Here are five things to know:
1. South Florida healthcare companies received $45.2 million in venture capital funding.
2. Companies that raised a smaller amount include Vigilant BioSciences and USARAD.
3. Life science interests is on the uptick and there is a big increase in platform companies and virtual biotech companies that partner with research organizations instead of establishing their own labs.
4. As an industry with a $3 trillion annual that isn’t likely to change quickly, investors see healthcare as a huge opportunity.
5. Nationally, venture capitalists invested $13.4 billion in the first quarter of 2015, covering 1,020 deals. This is down from the fourth quarter of 2014, but the fifth consecutive quarter of more than $10 billion.
More articles on orthopedic devices:
5 key trends in the surgical, operating microscope market
French university hospital adopts PediGuard
42 orthopedic, spine devices receive FDA 510(k) clearance in March
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
